Werewolf Therapeutics (HOWL) Interest & Investment Income (2020 - 2026)

Werewolf Therapeutics has reported Interest & Investment Income for 7 years, with the latest figure at $277000.0 in Q2 2026.

• Interest & Investment Income for Q2 2026 came in at $277000.0, down 67.41% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.0 million (down 58.54% YoY), and the FY2025 annual result was $3.1 million, down 53.42% from the prior year.
• Interest & Investment Income fell to $277000.0 in Q2 2026, from $433000.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.0 million in Q4 2023 and troughed at $39000.0 in Q1 2022.
• A 5-year average of $1.1 million and a median of $1.1 million in 2022 frame the typical range for Interest & Investment Income.
• The widest annual swing landed in 2023, when Interest & Investment Income soared 3794.87%; it then sank 67.41% in 2026.
• A 5-year view of Interest & Investment Income shows it stood at $1.2 million in 2022, then jumped by 67.51% to $2.0 million in 2023, then slumped by 33.72% to $1.3 million in 2024, then sank by 56.91% to $564000.0 in 2025, then tumbled by 50.89% to $277000.0 in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $277000.0 in Q2 2026, $433000.0 in Q1 2026, and $564000.0 in Q4 2025.